Skip to main content

Table 1 Clinicopathologic features of the 749 patients with nasopharyngeal carcinoma (NPC)

From: Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy

Feature No. of patients [cases (%)]
Sex
 Male 580 (77.4)
 Female 169 (22.6)
WHO pathology
 Type I 5 (0.7)
 Type II/III 744 (99.3)
Clinical stagea
 I–II 257 (34.3)
 III–IV 492 (65.7)
T stagea
 T1 177 (23.6)
 T2 140 (18.7)
 T3 264 (35.2)
 T4 168 (22.4)
N stagea
 N0 184 (24.6)
 N1 409 (54.6)
 N2 106 (14.2)
 N3 50 (6.7)
Chemotherapy
 No chemotherapy 214 (28.6)
 Concurrent 243(32.5)
 Induction + concurrent 246 (32.8)
 Concurrent + adjuvant 46 (6.1)
  1. WHO World Health Organization
  2. aAccording to the 7th edition of the Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) staging system